LEADERSHIP
Management Team
Eddie J. Sullivan, PhD
Co-Founder, President & CEO
Christoph Bausch, PhD
Chief Science Officer
Russell Beyer, CMA
Chief Financial Officer
Kipp Erickson, PhD
Chief Operating Officer
Rick Finnegan
Chief Business Officer
Tom Luke, MD
Chief Medical Officer
Jerry Pommer, MSc, PAS, DACAWS
Chief Compliance Officer
Melissa Ullerich
Chief Corporate Communications
Investor Relations Officer
Board of Directors
Samuel J. Reich
Executive Chairman
David Link
Vice Chairman
Former Executive Vice President
Sanford Health
Eddie J. Sullivan, PhD
Co-Founder, President, CEO
SAB Biotherapeutics
Christine Hamilton
Co-Founder, SAB Biotherapeutics
Managing Partner, Christiansen Land & Cattle
Co-Owner BioDak, LLC
Bill Polvino, MD
CEO
Bridge Medicines
Mervyn Turner, PhD
Former Head of Strategy
Merck
Jeffrey G. Spragens
Eddie Hamilton, DVM MAgr
Co-Founder, Board Observer
Scientific Advisory Board
Jim Robl, PhD
Retired Biotechnology Executive & Professor
Scott A. Lesley, Ph.D.
Vice President, Discovery Biologics
Merck Research Laboratories
Arturo Casadevall, MD, PhD
Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases
Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine
Michael Haller, MD, MS–CI
Chief, Program Director, Pediatric Endocrinology and Professor
University of Florida Medical Center
Stephen E. Gitelman, MD
Professor of Clinical Pediatrics
KAK Distinguished Professor in Pediatric Diabetes and Clinical Research
University of California-San Francisco